Quantitative Models and Construction Methods Factor Performance Tracking Single Factor Performance - Factors with the best performance in the CSI 300 stock pool this week include the standard deviation of 5-day trading volume (2.12%), the proportion of downside volatility (1.78%), and the 5-day exponential moving average of trading volume (1.35%) [1][12] - Factors with the worst performance in the CSI 300 stock pool this week include the 5-day reversal (-3.60%), single-quarter total asset gross profit margin (-3.43%), and single-quarter ROA (-3.38%) [1][12] - Factors with the best performance in the CSI 500 stock pool this week include the inverse of the P/E ratio TTM (3.99%), the proportion of downside volatility (3.80%), and the P/E ratio factor (3.17%) [14] - Factors with the worst performance in the CSI 500 stock pool this week include the 5-day reversal (-1.95%), 5-day average turnover rate (-1.17%), and the 5-day exponential moving average of trading volume (-1.15%) [14] - Factors with the best performance in the liquidity 1500 stock pool this week include the correlation between intraday volatility and trading volume (2.27%), the proportion of downside volatility (1.80%), and the P/B ratio factor (1.51%) [16] - Factors with the worst performance in the liquidity 1500 stock pool this week include single-quarter EPS (-1.36%), standardized unexpected income (-1.29%), and the 5-day reversal (-1.25%) [16] Major Factor Performance - In the overall market stock pool this week, the momentum factor achieved a positive return of 0.43%, indicating a momentum effect in the market [18] - The Beta factor, market capitalization factor, and non-linear market capitalization factor achieved negative returns of -1.50%, -0.91%, and -0.54%, respectively, indicating a small-cap style in the market [18] Industry Factor Performance - This week, fundamental factors showed varied performance across industries. The net asset growth rate factor, net profit growth rate factor, net asset per share factor, and operating profit per share TTM factor consistently achieved positive returns in the non-bank financial industry [22] - Among valuation factors, the BP factor and EP factor consistently achieved positive returns in the home appliances, comprehensive, and non-bank financial industries [22] - The residual volatility factor and liquidity factor showed significant positive returns in the coal industry [22] - In terms of market capitalization style, the food and beverage, beauty care, and banking industries showed a significant large-cap style this week [22] Factor Backtesting Results CSI 300 Stock Pool - Standard deviation of 5-day trading volume: 2.12% (1 week), 3.52% (1 month), 8.21% (1 year), 19.07% (10 years) [13] - Proportion of downside volatility: 1.78% (1 week), 0.41% (1 month), -5.44% (1 year), 25.57% (10 years) [13] - 5-day exponential moving average of trading volume: 1.35% (1 week), 1.19% (1 month), 3.70% (1 year), 5.13% (10 years) [13] CSI 500 Stock Pool - Inverse of P/E ratio TTM: 3.99% (1 week), 4.80% (1 month), -5.74% (1 year), 48.40% (10 years) [15] - Proportion of downside volatility: 3.80% (1 week), 1.56% (1 month), -3.09% (1 year), 107.51% (10 years) [15] - P/E ratio factor: 3.17% (1 week), 2.58% (1 month), -4.94% (1 year), 26.11% (10 years) [15] Liquidity 1500 Stock Pool - Correlation between intraday volatility and trading volume: 2.27% (1 week), 3.18% (1 month), 2.59% (1 year), 152.82% (10 years) [17] - Proportion of downside volatility: 1.80% (1 week), 2.97% (1 month), 5.48% (1 year), 114.63% (10 years) [17] - P/B ratio factor: 1.51% (1 week), 3.69% (1 month), -5.28% (1 year), 74.59% (10 years) [17] Portfolio Tracking PB-ROE-50 Portfolio Performance - This week, the PB-ROE-50 portfolio achieved positive excess returns in the CSI 500 stock pool: 0.15% [24] - In the CSI 800 stock pool, the PB-ROE-50 portfolio achieved excess returns of -1.50% [24] - In the overall market stock pool, the PB-ROE-50 portfolio achieved excess returns of -2.52% [24] Institutional Research Portfolio Tracking - This week, the public fund research stock selection strategy and private fund research tracking strategy achieved negative excess returns relative to the CSI 800: -0.94% and -4.83%, respectively [26] Block Trade Portfolio Tracking - This week, the block trade portfolio achieved positive excess returns relative to the CSI All Share Index: 1.56% [30] Private Placement Portfolio Tracking - This week, the private placement portfolio achieved positive excess returns relative to the CSI All Share Index: 1.86% [36]

Core Viewpoint - Betaini (300957.SZ), known as the "first stock in functional skincare," is intensifying its capital market strategy by investing in a new healthcare fund, aiming to diversify its business beyond its core beauty segment [1][11]. Investment Strategy - On October 13, Betaini announced plans to invest as a limited partner in the Wuxi Jinyu Maowu Medical Health Industry Investment Partnership (referred to as "Jinyu Fund"), with a total fund size of CNY 1 billion [1][7]. - The fund will focus on sectors such as consumer healthcare, medical aesthetics, specialty foods, pharmaceuticals, medical devices, and AI-driven drug development [1][7]. Financial Commitment - Betaini intends to contribute CNY 50 million, which will account for a 5% stake in the Jinyu Fund [1][7]. - Other partners in the fund include Jiangsu Wuxi Biomedical Industry Special Mother Fund (CNY 300 million), and Jiangyin High-tech Zone Financial Investment Co., Ltd. (CNY 250 million) [7]. Previous Investments - Over the past few years, Betaini has invested in several funds, including Sequoia Fund, San Zheng Fund, and Jinguo Fund, totaling approximately CNY 280 million across various sectors [1][11]. - Specific investments include CNY 100 million in the Sequoia Fund in June 2022, CNY 100 million in the San Zheng Fund in April 2023, and CNY 30 million in the Jinguo Fund in October 2023 [6][8]. Business Performance - Betaini's revenue growth has been declining, with revenues of CNY 40.22 billion, CNY 50.14 billion, CNY 55.22 billion, and CNY 57.36 billion from 2021 to 2024, showing a decreasing growth rate [11]. - The net profit has also decreased significantly, from CNY 8.63 billion in 2021 to CNY 5.03 billion in 2024, indicating a trend of increasing revenue but declining profitability [11]. Market Context - The beauty industry is witnessing a trend where major brands, including Betaini, are increasingly investing in capital markets to seek growth opportunities amid slowing core business performance [11][12]. - Competitors like Proya and Marubi are also exploring similar investment strategies to enhance their market positions and seek new growth avenues [12][13].

Core Viewpoint - Betaini, known as the "first stock in functional skincare," is increasing its capital investments to explore new business opportunities amid declining performance in its core skincare segment [1][9]. Investment Strategy - On October 13, Betaini announced plans to invest as a limited partner in the Wuxi Jinyu Maowu Medical Health Industry Investment Partnership, with a total fund size of 1 billion CNY, focusing on consumer healthcare, pharmaceuticals, medical devices, and AI in drug development [1][5]. - Betaini will contribute 50 million CNY, holding a 5% stake in the fund, which aims to enhance the company's competitive edge and profitability through strategic partnerships in the health ecosystem [5][9]. Financial Performance - Betaini's revenue from 2021 to 2024 showed a declining growth trend, with revenues of 40.22 billion CNY, 50.14 billion CNY, 55.22 billion CNY, and 57.36 billion CNY, reflecting year-on-year growth rates of 52.57%, 24.65%, 10.14%, and 3.87% respectively [9][10]. - The net profit during the same period was 8.63 billion CNY, 10.51 billion CNY, 7.57 billion CNY, and 5.03 billion CNY, with year-on-year growth rates of 58.77%, 21.82%, -28.02%, and -33.53%, indicating a trend of increasing revenue but decreasing profit [10]. Brand Dependency - The company's revenue heavily relies on its core brand "Winona," which contributed 48.85 billion CNY, 51.92 billion CNY, and 49.09 billion CNY from 2022 to 2024, accounting for approximately 97%, 94%, and 86% of total revenue respectively [10]. Diversification Efforts - To mitigate risks associated with reliance on a single brand, Betaini is developing a multi-brand strategy, acquiring stakes in other brands such as "Za" and "PURE&MILD" to expand its business portfolio [10][11]. - The company has invested approximately 280 million CNY in various funds over the past three years, indicating a proactive approach to diversify its investment portfolio beyond its primary beauty business [5][9]. Market Trends - The beauty industry is witnessing a trend where leading brands, including Betaini, are increasingly investing in capital markets to seek growth opportunities amid slowing sales in their core businesses [9][12].

Core Viewpoint - Betaini (300957.SZ), known as the "first stock in functional skincare," is intensifying its capital market strategy by investing in a new healthcare fund, aiming to diversify its business beyond its core beauty segment [1]. Investment Strategy - On October 13, Betaini announced plans to invest as a limited partner in the Wuxi Jinyu Maowu Medical Health Industry Investment Partnership (referred to as "Jinyu Fund"), with a total fund size of 1 billion CNY, focusing on consumer healthcare, pharmaceuticals, medical devices, and AI drug development [1][4]. - Betaini will contribute 50 million CNY, acquiring a 5% stake in the Jinyu Fund, which is part of a broader strategy to deepen cooperation with professional funds and enhance its presence in the health ecosystem [4]. Historical Investments - Over the past three years, Betaini has invested approximately 280 million CNY in various funds, including the Sequoia Fund and the San Zheng Fund, indicating a strategic shift towards capital investments to seek growth opportunities [3][9]. - The company has made several notable investments: 100 million CNY in the Sequoia Fund in June 2022, another 100 million CNY in the San Zheng Fund in April 2023, and 30 million CNY in the Jinguo Fund in October 2023 [5][9]. Financial Performance - Betaini's revenue growth has been declining, with reported revenues of 4.022 billion CNY in 2021, 5.014 billion CNY in 2022, 5.522 billion CNY in 2023, and 5.736 billion CNY in 2024, showing a decreasing growth rate from 52.57% to 3.87% [9]. - The net profit has also seen a downward trend, with figures of 863 million CNY in 2021, 1.051 billion CNY in 2022, 757 million CNY in 2023, and 503 million CNY in 2024, reflecting a significant decline in profitability [9]. Market Position and Competition - Betaini's core brand, Winona, has been a major revenue driver, contributing approximately 97% of total revenue in 2022, which decreased to around 86% in 2024, indicating a heavy reliance on a single brand [9]. - Other beauty brands, such as Proya and Marubi, are also increasing their capital investments to seek growth, highlighting a trend among leading beauty companies to diversify and enhance their market positions [10][11].

Core Viewpoint - The A-share market experienced a decline today, with the Shanghai Composite Index dropping by 1.39% and trading volume decreasing by 4.76% compared to the previous trading day [1] Industry Performance Summary - **Coal**: Slight increase of 0.12% with a transaction amount of 165.48 billion yuan, led by Antai Group which rose by 10.00% [1] - **Banking**: Minor decrease of 0.04% with a transaction amount of 302.99 billion yuan, led by Shanghai Bank which fell by 0.83% [1] - **Steel**: Decrease of 0.09% with a transaction amount of 133.07 billion yuan, led by Wujin Stainless Steel which dropped by 7.73% [1] - **Transportation**: Decrease of 0.11% with a transaction amount of 258.60 billion yuan, led by Pulutong which fell by 3.36% [1] - **Textiles and Apparel**: Decrease of 0.25% with a transaction amount of 119.79 billion yuan, led by Yingfeng Shares which dropped by 9.99% [1] - **Oil and Petrochemicals**: Decrease of 0.29% with a transaction amount of 83.04 billion yuan, led by Compton which fell by 3.19% [1] - **Agriculture, Forestry, Animal Husbandry, and Fishery**: Decrease of 0.45% with a transaction amount of 139.82 billion yuan, led by Aonong Biological which dropped by 4.66% [1] - **Real Estate**: Decrease of 0.52% with a transaction amount of 213.60 billion yuan, led by Wolong New Energy which fell by 7.80% [1] - **Utilities**: Decrease of 0.52% with a transaction amount of 302.04 billion yuan, led by *ST Lingda which dropped by 13.20% [1] - **Construction and Decoration**: Decrease of 0.75% with a transaction amount of 278.81 billion yuan, led by Kexin Development which fell by 8.15% [1] - **Home Appliances**: Decrease of 0.79% with a transaction amount of 217.37 billion yuan, led by Greer which dropped by 6.72% [1] - **Food and Beverage**: Decrease of 0.86% with a transaction amount of 194.67 billion yuan, led by Huaiqi Mountain which fell by 6.44% [1] - **Environmental Protection**: Decrease of 0.92% with a transaction amount of 140.79 billion yuan, led by Science which dropped by 6.68% [1] - **Retail**: Decrease of 0.97% with a transaction amount of 173.43 billion yuan, led by Ruoyu Chen which fell by 9.98% [1] - **Social Services**: Decrease of 1.07% with a transaction amount of 89.87 billion yuan, led by Chuangye Heima which dropped by 5.28% [1] - **Light Industry Manufacturing**: Decrease of 1.12% with a transaction amount of 135.66 billion yuan, led by Songyang Resources which fell by 10.02% [1] - **Pharmaceuticals and Biology**: Decrease of 1.16% with a transaction amount of 845.22 billion yuan, led by Warner Pharmaceuticals which dropped by 7.67% [1] - **Basic Chemicals**: Decrease of 1.21% with a transaction amount of 618.91 billion yuan, led by Xinong Shares which fell by 8.88% [1] - **Non-ferrous Metals**: Decrease of 1.24% with a transaction amount of 1149.11 billion yuan, led by Galaxy Magnetics which dropped by 7.14% [1] - **Telecommunications**: Decrease of 1.28% with a transaction amount of 806.90 billion yuan, led by Shijia Photon which fell by 17.59% [1] - **Non-bank Financials**: Decrease of 1.39% with a transaction amount of 491.74 billion yuan, led by Hainan Huatie which dropped by 6.17% [1] - **Building Materials**: Decrease of 1.66% with a transaction amount of 94.02 billion yuan, led by Yaopi Glass which fell by 7.82% [1] - **Media**: Decrease of 1.68% with a transaction amount of 263.96 billion yuan, led by Vision China which dropped by 9.93% [1] - **Beauty and Personal Care**: Decrease of 1.76% with a transaction amount of 33.94 billion yuan, led by Baiya Shares which fell by 4.98% [1] - **Computers**: Decrease of 2.38% with a transaction amount of 1005.18 billion yuan, led by Kaipu Cloud which dropped by 11.94% [1] - **Comprehensive**: Decrease of 2.42% with a transaction amount of 27.84 billion yuan, led by Dongyangguang which fell by 4.70% [1] - **Defense and Military Industry**: Decrease of 2.55% with a transaction amount of 387.73 billion yuan, led by Hangyu Technology which dropped by 8.38% [1] - **Machinery and Equipment**: Decrease of 2.68% with a transaction amount of 940.87 billion yuan, led by Yingweike which fell by 10.00% [1] - **Automobiles**: Decrease of 2.69% with a transaction amount of 775.95 billion yuan, led by Tianpu Shares which dropped by 10.00% [1] - **Electronics**: Decrease of 3.19% with a transaction amount of 2631.19 billion yuan, led by Nanya New Materials which fell by 16.26% [1] - **Electric Power Equipment**: Decrease of 3.79% with a transaction amount of 1881.52 billion yuan, led by Shenghong Shares which dropped by 11.80% [1]

Core Viewpoint - After the double festival, technology stocks experienced a significant correction, while liquor stocks rebounded, leading to discussions about style switching in the market [1] Group 1: Industry Dynamics - During the double festival, liquor sales overall declined by 20%-30%, with high-end liquor prices dropping, enhancing their cost-effectiveness [2] - Guizhou Moutai held a marketing seminar for its sauce-flavored liquor series on October 15, signaling a recovery in sales, with a noticeable month-on-month increase in terminal sales since September [2] - The upcoming sugar and liquor conference in Nanjing from October 16-18 is expected to show marginal improvements in the industry after the correction of the alcohol ban [2] - The M2-M1 gap in September reached a year-low of 1.2 percentage points, indicating a shift towards more liquid loans, which could benefit consumption and investment [2] - Domestic economic stability is anticipated to gradually improve, with cyclical industries like liquor expected to re-enter a high growth phase [2] Group 2: Investment Opportunities - Notable investment targets include the Food and Beverage ETF (515170), which has seen a net inflow of over 800 million yuan over four consecutive days, focusing on liquor, dairy, and seasoning products [3] - The Consumption 30 ETF (510630) covers a full industry chain including liquor, food, and beauty care, tracking the Shanghai Consumer Index with key stocks like Yili, Guizhou Moutai, and Shanxi Fenjiu [3]

Market Overview - The Chinese yuan's midpoint exchange rate rose to 7.10 against the US dollar, marking the first increase since November of the previous year, with a reported adjustment of 26 points from the previous day's midpoint of 7.1021 [3] - The offshore yuan experienced a significant increase, coinciding with a broad rebound in equity markets, particularly in the pharmaceutical and consumer sectors [3] Sector Performance - The pharmaceutical sector saw notable gains, with stocks like Guangsheng Tang hitting a 20% limit up and Shutai Shen rising over 16% [3] - The consumer sector, including automotive, white goods, beauty care, and home textiles, also showed strong performance, leading the market in gains [3] Key Corporate Developments - A market rumor suggested that Tesla placed a substantial order worth $685 million for linear actuators from Chinese supplier Sanhua Intelligent Control, which led to a surge in Sanhua's stock price [4] - New Kylin's subsidiary, Qiyunfang, launched two domestically developed EDA design software products at the 2025 Bay Chip Expo, addressing a gap in high-end electronic design software in China [5] - ASML reported better-than-expected orders of €5.4 billion (approximately $6.3 billion) for the third quarter, driven by demand for chip manufacturing equipment related to artificial intelligence [6][7] - ASML's CEO indicated a positive momentum in AI investments, with expectations that net sales will not fall below 2025 levels [8] Market Dynamics - The overall market experienced a decrease in trading volume, with a total turnover of 2.07 trillion yuan, down 503.4 billion from the previous trading day [8] - There is a shift in market focus towards consumer and pharmaceutical sectors, while previously popular sectors like ports, shipping, and rare metals are experiencing a pullback [8] - The current market environment is characterized by a healthy consolidation phase, allowing for a reassessment of positions as the third-quarter reporting season approaches [8]

Core Points - The Shanghai Composite Index rose by 0.10% today, with a trading volume of 827.71 million shares and a total transaction value of 1,280.495 billion yuan, a decrease of 23.83% compared to the previous trading day [1][2] - A total of 3,296 stocks increased in value, with 51 hitting the daily limit up, while 1,952 stocks declined, including 6 hitting the daily limit down [1][2] Industry Performance - The top-performing sectors included: - Beauty and Personal Care: Increased by 2.50%, with a transaction value of 45.93 billion yuan, up 57.56% from the previous day, led by Shanghai Jahwa, which rose by 10.00% [1] - Retail: Increased by 1.69%, with a transaction value of 203.51 billion yuan, up 33.09%, led by Guoguang Chain, which rose by 10.00% [1] - Pharmaceutical and Biological: Increased by 1.49%, with a transaction value of 698.26 billion yuan, up 14.92%, led by Guangsheng Tang, which rose by 20.00% [1] - The sectors with the largest declines included: - Defense and Military: Decreased by 1.49%, with a transaction value of 342.54 billion yuan, down 35.37%, led by Beifang Changlong, which fell by 10.39% [2] - Non-ferrous Metals: Decreased by 1.23%, with a transaction value of 1,244.15 billion yuan, down 24.08%, led by Shandong Gold, which fell by 6.67% [2] - Steel: Decreased by 0.74%, with a transaction value of 131.04 billion yuan, down 34.92%, led by Guangdong Mingzhu, which fell by 7.73% [2]

Core Viewpoint - The A-share market is experiencing a "weight protection and theme differentiation" pattern, with the Shanghai Composite Index slightly rising by 0.1% to maintain 3869 points, while the Hong Kong market sees a comprehensive rebound driven by technology and consumer sectors [1][2]. Market Performance - The Shanghai Composite Index closed at 3869.25 points, up 0.1%, while the Shenzhen Component Index remained flat and the ChiNext Index rose by 0.22%. Over 3200 stocks in the market increased, but trading volume significantly decreased to 1.28 trillion yuan, down 401 billion yuan from the previous day, indicating a rise in cautious sentiment among investors [2]. - The Hong Kong market saw the Hang Seng Index rise by 1.21% to 25749.68 points, with the Hang Seng Technology Index up 1.18%, driven by inflows from southbound funds exceeding 3 billion HKD, focusing on policy-sensitive sectors like building materials and aviation [2]. Industry Highlights and Driving Logic - Defensive consumption and pharmaceutical sectors led the gains in the A-share market, with the pharmaceutical and biotechnology sector rising by 1.60%, driven by anticipation of the upcoming ESMO conference on October 17, prompting institutional investors to position themselves in innovative drug developments [3]. - In the Hong Kong market, the non-essential consumption index increased by 2.06%, benefiting from improved consumption data post-National Day and ongoing policy support for domestic demand. Building materials and cement stocks rebounded strongly, with expectations of improved profitability from overseas operations [3]. Declining Sectors and Driving Logic - The resource sector experienced a collective pullback, with the A-share rare earth permanent magnet index dropping over 5%, influenced by a stronger US dollar and fluctuations in commodity prices, raising concerns about a global economic slowdown [4]. - The technology growth sector showed differentiation, with the A-share photolithography machine concept plummeting and the semiconductor industry facing widespread declines due to external technology restrictions, although there were signs of recovery in computing power and GPU sectors later in the day [4]. Investment Strategy Recommendations - The current market is at a critical juncture of "third-quarter report verification + policy anticipation," suggesting a focus on three main lines for the fourth quarter: - Positioning in the technology growth sector based on industry trends, particularly in the AI industry chain, which remains promising despite short-term volatility, and monitoring innovative drug developments ahead of the ESMO conference [5]. - Capitalizing on the dual drivers of policy and supply-demand dynamics in cyclical and resource sectors, with a focus on non-ferrous metals benefiting from global easing expectations and potential recovery signals in the photovoltaic sector [5]. Policy-Driven Opportunities - Opportunities are concentrated in forward-looking areas of the "14th Five-Year Plan," with high-end manufacturing sectors like industrial robots and semiconductor equipment benefiting from self-sufficiency policies, and the consumer sector poised for recovery during the "Double 11" shopping festival [6]. - A balanced allocation between defensive consumption and undervalued cyclical stocks is recommended in the short term, while long-term strategies should focus on AI computing power and high-end manufacturing, creating a defensive system that combines policy safety and industry growth potential [6].

Market Overview - The market continues to experience fluctuations, with technology stocks undergoing adjustments while individual stock performances dominate [2] - The pharmaceutical sector, which had previously seen significant adjustments, is rebounding alongside consumer goods, becoming a new focus for funds [2] - The Shanghai Composite Index rose by 0.1%, while the Shenzhen Component Index remained flat, and the ChiNext Index increased by 0.22% [2] Pharmaceutical Sector - Pharmaceutical stocks are experiencing a rebound, particularly in cell immunotherapy, innovative drugs, and medical services [4] - Notable stocks include Guangsheng Tang, which hit a "20CM" limit up, and Shutaishen, which rose over 14% [2][4] - The innovative drug sector has been strong in the first half of the year but has seen fluctuations since mid-August [6] Investment Logic in Innovative Drugs - Institutions believe the investment logic for the innovative drug sector may shift from sentiment-driven to fundamentals-driven [7] - Market focus is expected to shift towards leading companies with actual benefits, especially those with established products or strong clinical trial progress [7] - The European Society for Medical Oncology (ESMO) conference, scheduled for October 17-21, 2025, is anticipated to be a key catalyst for the innovative drug sector [7] Quantum Technology Sector - The quantum technology sector is witnessing an uptick, with stocks like Hexin Instruments and Geer Software experiencing significant gains [8] - Recent announcements, including the Nobel Prize in Physics awarded for contributions to quantum mechanics, are expected to enhance interest in quantum technology [9][10] - The global quantum computing market is projected to grow from $1.1 billion in 2022 to approximately $7.6 billion by 2027 [10]